Gene Products for Diagnosis and Therapy

Simple SummaryContent extracted from patent full text and abstract with AI.

This invention relates to a pharmaceutical composition and method that inhibits the expression or activity of tumor-associated antigens. The technology is designed for use in the diagnosis and treatment of tumors, especially cancers, by targeting specific structures linked to the disease.

Use CasesContent extracted from patent full text and abstract with AI.

• Targeted cancer therapy to treat different types of tumors by inhibiting tumor-associated antigens.
• Diagnostic tests to identify the presence or progression of cancer using tumor-associated antigens as markers.
• Personalized medicine approaches based on the tumor antigen profile of individual patients.
• Development of drugs aimed specifically at blocking tumor antigen activity.

BenefitsContent extracted from patent full text and abstract with AI.

• Allows more specific targeting of cancer cells, potentially reducing side effects compared to traditional chemotherapy.
• Enables both treatment and diagnosis, supporting earlier and more accurate cancer detection.
• Can be adapted for use in various types of cancers due to the focus on tumor-associated antigens.
• Opens pathways for personalized therapy based on unique tumor markers.

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

Die Erfindung betrifft eine Pharmazeutische Zusammensetzung, umfassend ein Mittel, das die Expression oder Aktivität eines Tumor-assoziierten Antigens inhibiert, sowie ein Verfahren zur Behandlung und Diagnose einer Tumorerkrankung. Diese Mittel und Verfahren ermöglichen es, Zielstrukturen für eine Diagnose und Therapie von Erkrankungen, insbesondere Krebserkrankungen bereit zu stellen.